{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:49:26Z","timestamp":1792507766155,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T00:00:00Z","timestamp":1573171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T00:00:00Z","timestamp":1573171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG044263"],"award-info":[{"award-number":["AG044263"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG060974"],"award-info":[{"award-number":["AG060974"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1U01NS110437-01"],"award-info":[{"award-number":["1U01NS110437-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["2016-00748"],"award-info":[{"award-number":["2016-00748"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["A2019488F"],"award-info":[{"award-number":["A2019488F"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["2018-AARF-591935"],"award-info":[{"award-number":["2018-AARF-591935"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Summary<\/jats:title>\n<jats:p>The detection of amyloid beta deposits and neurofibrillary tangles, both hallmarks of Alzheimer\u2019s disease (AD), is key to understanding the mechanisms underlying these pathologies. Luminescent conjugated oligothiophenes (LCOs) enable fluorescence imaging of these protein aggregates. Using LCOs and multiphoton microscopy, individual tangles and amyloid beta deposits were labeled in vivo and imaged longitudinally in a mouse model of tauopathy and cerebral amyloidosis, respectively. Importantly, LCO HS-84, whose emission falls in the green region of the spectrum, allowed for the first time longitudinal imaging of tangle dynamics following a single intravenous injection. In addition, LCO HS-169, whose emission falls in the red region of the spectrum, successfully labeled amyloid beta deposits, allowing multiplexing with other reporters whose emission falls in the green region of the spectrum. In conclusion, this method can provide a new approach for longitudinal in vivo imaging using multiphoton microscopy of AD pathologies as well as other neurodegenerative diseases associated with protein aggregation in mouse models.<\/jats:p>","DOI":"10.1186\/s40478-019-0832-1","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T14:45:09Z","timestamp":1573224309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["In vivo detection of tau fibrils and amyloid \u03b2 aggregates with luminescent conjugated oligothiophenes and multiphoton microscopy"],"prefix":"10.1186","volume":"7","author":[{"given":"Maria","family":"Calvo-Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven S.","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin C.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Dujardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Shirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Peter R.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Bacskai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,8]]},"reference":[{"key":"832_CR1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","volume":"45","author":"JL Price","year":"1999","unstructured":"Price JL, Morris JC (1999) Tangles and plaques in nondemented aging and \u201cpreclinical\u201d Alzheimer's disease. Ann Neurol 45:358\u2013368","journal-title":"Ann Neurol"},{"key":"832_CR2","doi-asserted-by":"publisher","first-page":"8356","DOI":"10.1039\/c1ob05637a","volume":"9","author":"T Klingstedt","year":"2011","unstructured":"Klingstedt T, Aslund A, Simon RA, Johansson LB, Mason JJ, Nystrom S, Hammarstrom P, Nilsson KP (2011) Synthesis of a library of oligothiophenes and their utilization as fluorescent ligands for spectral assignment of protein aggregates. Org Biomol Chem 9:8356\u20138370. \nhttps:\/\/doi.org\/10.1039\/c1ob05637a","journal-title":"Org Biomol Chem"},{"key":"832_CR3","doi-asserted-by":"publisher","first-page":"15133","DOI":"10.1002\/chem.201502999","volume":"21","author":"H Shirani","year":"2015","unstructured":"Shirani H, Linares M, Sigurdson CJ, Lindgren M, Norman P, Nilsson KP (2015) A palette of fluorescent Thiophene-based ligands for the identification of protein aggregates. Chemistry 21:15133\u201315137. \nhttps:\/\/doi.org\/10.1002\/chem.201502999","journal-title":"Chemistry"},{"key":"832_CR4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4161\/pri.29239","volume":"8","author":"K Magnusson","year":"2014","unstructured":"Magnusson K, Simon R, Sjolander D, Sigurdson CJ, Hammarstrom P, Nilsson KP (2014) Multimodal fluorescence microscopy of prion strain specific PrP deposits stained by thiophene-based amyloid ligands. Prion 8:319\u2013329. \nhttps:\/\/doi.org\/10.4161\/pri.29239","journal-title":"Prion"},{"key":"832_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3389\/fnins.2015.00184","volume":"9","author":"J Brelstaff","year":"2015","unstructured":"Brelstaff J, Ossola B, Neher JJ, Klingstedt T, Nilsson KP, Goedert M, Spillantini MG, Tolkovsky AM (2015) The fluorescent pentameric oligothiophene pFTAA identifies filamentous tau in live neurons cultured from adult P301S tau mice. Front Neurosci 9:184. \nhttps:\/\/doi.org\/10.3389\/fnins.2015.00184","journal-title":"Front Neurosci"},{"key":"832_CR6","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1021\/cb900112v","volume":"4","author":"A Aslund","year":"2009","unstructured":"Aslund A, Sigurdson CJ, Klingstedt T, Grathwohl S, Bolmont T, Dickstein DL, Glimsdal E, Prokop S, Lindgren M, Konradsson P et al (2009) Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses. ACS Chem Biol 4:673\u2013684. \nhttps:\/\/doi.org\/10.1021\/cb900112v","journal-title":"ACS Chem Biol"},{"key":"832_CR7","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.nbd.2006.08.017","volume":"24","author":"M Garcia-Alloza","year":"2006","unstructured":"Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, Raju S, Prada C, Greenberg SM, Bacskai BJ, Frosch MP (2006) Characterization of amyloid deposition in the APPswe\/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis 24:516\u2013524. \nhttps:\/\/doi.org\/10.1016\/j.nbd.2006.08.017","journal-title":"Neurobiol Dis"},{"key":"832_CR8","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1126\/science.1113694","volume":"309","author":"K Santacruz","year":"2005","unstructured":"Santacruz K, Lewis J, Spires T, Paulson J, Kotilinek L, Ingelsson M, Guimaraes A, DeTure M, Ramsden M, McGowan E et al (2005) Tau suppression in a neurodegenerative mouse model improves memory function. Science 309:476\u2013481. \nhttps:\/\/doi.org\/10.1126\/science.1113694","journal-title":"Science"},{"key":"832_CR9","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.ajpath.2017.03.011","volume":"187","author":"RE Bennett","year":"2017","unstructured":"Bennett RE, DeVos SL, Dujardin S, Corjuc B, Gor R, Gonzalez J, Roe AD, Frosch MP, Pitstick R, Carlson GA et al (2017) Enhanced tau aggregation in the presence of amyloid beta. Am J Pathol 187:1601\u20131612. \nhttps:\/\/doi.org\/10.1016\/j.ajpath.2017.03.011","journal-title":"Am J Pathol"},{"key":"832_CR10","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.neuron.2008.06.008","volume":"59","author":"KV Kuchibhotla","year":"2008","unstructured":"Kuchibhotla KV, Goldman ST, Lattarulo CR, Wu HY, Hyman BT, Bacskai BJ (2008) Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 59:214\u2013225. \nhttps:\/\/doi.org\/10.1016\/j.neuron.2008.06.008","journal-title":"Neuron"},{"key":"832_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13024-017-0169-9","volume":"12","author":"M Arbel-Ornath","year":"2017","unstructured":"Arbel-Ornath M, Hudry E, Boivin JR, Hashimoto T, Takeda S, Kuchibhotla KV, Hou S, Lattarulo CR, Belcher AM, Shakerdge N et al (2017) Soluble oligomeric amyloid-beta induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain. Mol Neurodegener 12:27. \nhttps:\/\/doi.org\/10.1186\/s13024-017-0169-9","journal-title":"Mol Neurodegener"},{"key":"832_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/laban0511-155","volume":"40","author":"T Yardeni","year":"2011","unstructured":"Yardeni T, Eckhaus M, Morris HD, Huizing M, Hoogstraten-Miller S (2011) Retro-orbital injections in mice. Lab Anim 40:155\u2013160. \nhttps:\/\/doi.org\/10.1038\/laban0511-155","journal-title":"Lab Anim"},{"key":"832_CR13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/jnen\/61.9.797","volume":"61","author":"WE Klunk","year":"2002","unstructured":"Klunk WE, Bacskai BJ, Mathis CA, Kajdasz ST, McLellan ME, Frosch MP, Debnath ML, Holt DP, Wang Y, Hyman BT (2002) Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative. J Neuropathol Exp Neurol 61:797\u2013805","journal-title":"J Neuropathol Exp Neurol"},{"key":"832_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/2051-5960-2-63","volume":"2","author":"N Rudinskiy","year":"2014","unstructured":"Rudinskiy N, Hawkes JM, Wegmann S, Kuchibhotla KV, Muzikansky A, Betensky RA, Spires-Jones TL, Hyman BT (2014) Tau pathology does not affect experience-driven single-neuron and network-wide arc\/Arg3.1 responses. Acta Neuropathol Commun 2:63. \nhttps:\/\/doi.org\/10.1186\/2051-5960-2-63","journal-title":"Acta Neuropathol Commun"},{"key":"832_CR15","doi-asserted-by":"publisher","first-page":"7873","DOI":"10.1523\/JNEUROSCI.22-18-07873.2002","volume":"22","author":"BJ Bacskai","year":"2002","unstructured":"Bacskai BJ, Kajdasz ST, McLellan ME, Games D, Seubert P, Schenk D, Hyman BT (2002) Non-fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy. J Neurosci 22:7873\u20137878","journal-title":"J Neurosci"},{"key":"832_CR16","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E","volume":"48","author":"GA Jicha","year":"1997","unstructured":"Jicha GA, Bowser R, Kazam IG, Davies P (1997) Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res 48:128\u2013132","journal-title":"J Neurosci Res"},{"key":"832_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1117\/12.470705","volume":"4620","author":"EJ Yoder","year":"2002","unstructured":"Yoder EJ (2002) In vivo microscopy of the mouse brain using multiphoton laser scanning techniques. Int Soc Opt Eng 4620:14\u201329. \nhttps:\/\/doi.org\/10.1117\/12.470705","journal-title":"Int Soc Opt Eng"},{"key":"832_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/srep00019","volume":"1","author":"C Condello","year":"2011","unstructured":"Condello C, Schain A, Grutzendler J (2011) Multicolor time-stamp reveals the dynamics and toxicity of amyloid deposition. Sci Rep 1:19. \nhttps:\/\/doi.org\/10.1038\/srep00019","journal-title":"Sci Rep"},{"key":"832_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/978-1-61779-551-0_28","volume":"849","author":"HB Rajamohamedsait","year":"2012","unstructured":"Rajamohamedsait HB, Sigurdsson EM (2012) Histological staining of amyloid and pre-amyloid peptides and proteins in mouse tissue. Methods Mol Biol 849:411\u2013424. \nhttps:\/\/doi.org\/10.1007\/978-1-61779-551-0_28","journal-title":"Methods Mol Biol"},{"key":"832_CR20","doi-asserted-by":"publisher","first-page":"9572","DOI":"10.1523\/JNEUROSCI.2854-04.2004","volume":"24","author":"TA Pologruto","year":"2004","unstructured":"Pologruto TA, Yasuda R, Svoboda K (2004) Monitoring neural activity and [Ca2+] with genetically encoded Ca2+ indicators. J Neurosci 24:9572\u20139579. \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.2854-04.2004","journal-title":"J Neurosci"},{"key":"832_CR21","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1039\/c7cs00706j","volume":"47","author":"P Verwilst","year":"2018","unstructured":"Verwilst P, Kim HS, Kim S, Kang C, Kim JS (2018) Shedding light on tau protein aggregation: the progress in developing highly selective fluorophores. Chem Soc Rev 47:2249\u20132265. \nhttps:\/\/doi.org\/10.1039\/c7cs00706j","journal-title":"Chem Soc Rev"},{"key":"832_CR22","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1073\/pnas.1318807111","volume":"111","author":"KV Kuchibhotla","year":"2014","unstructured":"Kuchibhotla KV, Wegmann S, Kopeikina KJ, Hawkes J, Rudinskiy N, Andermann ML, Spires-Jones TL, Bacskai BJ, Hyman BT (2014) Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo. Proc Natl Acad Sci U S A 111:510\u2013514. \nhttps:\/\/doi.org\/10.1073\/pnas.1318807111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"832_CR23","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ebiom.2018.08.041","volume":"35","author":"Q Wu","year":"2018","unstructured":"Wu Q, Lin Y, Gu J, Sigurdsson EM (2018) Dynamic assessment of tau immunotherapies in the brains of live animals by two-photon imaging. EBioMed 35:270\u2013278. \nhttps:\/\/doi.org\/10.1016\/j.ebiom.2018.08.041","journal-title":"EBioMed"},{"key":"832_CR24","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/j.ajpath.2012.08.031","volume":"181","author":"BM Wegenast-Braun","year":"2012","unstructured":"Wegenast-Braun BM, Skodras A, Bayraktar G, Mahler J, Fritschi SK, Klingstedt T, Mason JJ, Hammarstrom P, Nilsson KP, Liebig C et al (2012) Spectral discrimination of cerebral amyloid lesions after peripheral application of luminescent conjugated oligothiophenes. Am J Pathol 181:1953\u20131960. \nhttps:\/\/doi.org\/10.1016\/j.ajpath.2012.08.031","journal-title":"Am J Pathol"},{"key":"832_CR25","doi-asserted-by":"publisher","first-page":"13018","DOI":"10.1073\/pnas.1713215114","volume":"114","author":"J Rasmussen","year":"2017","unstructured":"Rasmussen J, Mahler J, Beschorner N, Kaeser SA, Hasler LM, Baumann F, Nystrom S, Portelius E, Blennow K, Lashley T et al (2017) Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer's disease. Proc Natl Acad Sci U S A 114:13018\u201313023. \nhttps:\/\/doi.org\/10.1073\/pnas.1713215114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"832_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00401-015-1515-z","volume":"131","author":"AC McKee","year":"2016","unstructured":"McKee AC, Cairns NJ, Dickson DW, Folkerth RD, Keene CD, Litvan I, Perl DP, Stein TD, Vonsattel JP, Stewart W et al (2016) The first NINDS\/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta Neuropathol 131:75\u201386. \nhttps:\/\/doi.org\/10.1007\/s00401-015-1515-z","journal-title":"Acta Neuropathol"},{"key":"832_CR27","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","volume":"12","author":"MG Spillantini","year":"2013","unstructured":"Spillantini MG, Goedert M (2013) Tau pathology and neurodegeneration. Lancet Neurol 12:609\u2013622. \nhttps:\/\/doi.org\/10.1016\/S1474-4422(13)70090-5","journal-title":"Lancet Neurol"},{"key":"832_CR28","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1161\/STROKEAHA.108.536839","volume":"40","author":"EE Smith","year":"2009","unstructured":"Smith EE, Greenberg SM (2009) Beta-amyloid, blood vessels, and brain function. Stroke 40:2601\u20132606. \nhttps:\/\/doi.org\/10.1161\/STROKEAHA.108.536839","journal-title":"Stroke"},{"key":"832_CR29","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJM200008103430607","volume":"343","author":"JW Hoppener","year":"2000","unstructured":"Hoppener JW, Ahren B, Lips CJ (2000) Islet amyloid and type 2 diabetes mellitus. N Engl J Med 343:411\u2013419. \nhttps:\/\/doi.org\/10.1056\/NEJM200008103430607","journal-title":"N Engl J Med"},{"key":"832_CR30","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2119\/2007-00100.Irvine","volume":"14","author":"GB Irvine","year":"2008","unstructured":"Irvine GB, El-Agnaf OM, Shankar GM, Walsh DM (2008) Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases. Mol Med 14:451\u2013464. \nhttps:\/\/doi.org\/10.2119\/2007-00100.Irvine","journal-title":"Mol Med"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0832-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-019-0832-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0832-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:51:32Z","timestamp":1604710292000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-019-0832-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,8]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["832"],"URL":"https:\/\/doi.org\/10.1186\/s40478-019-0832-1","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,8]]},"assertion":[{"value":"9 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Mouse experiments were performed with the approval of the Massachusetts General Hospital Animal Care and in compliance with the National Institutes of Health guidelines for the use of experimental animals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"171"}}